The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

Abstract

The findings of this study suggest that PTX could be a promising adjunct to antidepressants in the treatment of MDD patients.